Obesity Treatment Insurance Denied in Texas? How to Fight Back

Texas has one of the highest rates of obesity in the United States, yet health insurers routinely deny coverage for the treatments proven to address it — from GLP-1 medications like semaglutide (Wegovy) and tirzepatide (Zepbound) to bariatric surgery and structured weight management programs. If your obesity treatment has been denied in Texas, here is how to fight back.

Why Insurers Deny Obesity Treatment in Texas

GLP-1 drugs excluded as "weight loss medications." Many Texas insurance plans categorically exclude "weight loss drugs" from coverage. Even though GLP-1 receptor agonists have FDA approval for chronic weight management and proven cardiovascular benefits, insurers treat them as optional lifestyle drugs rather than medical treatments.

Bariatric surgery denied on medical necessity grounds. Insurers require strict BMI thresholds (typically BMI ≥40 or ≥35 with significant comorbidities), documented supervised diet program completion, and specific psychological and nutritional evaluations before approving bariatric surgery.

Supervised diet program not completed with an approved provider. Many plans require a 3–6 month medically supervised weight management program through a specific network of providers. Completing a similar program elsewhere may not satisfy the requirement.

Step therapy. Insurers may require trial and failure of multiple medications and behavioral programs before approving GLP-1 drugs or surgery.

Comorbidity requirement not satisfied. Plans may deny obesity treatment unless specific comorbidities are documented — even though obesity is itself a recognized disease.

Self-insured employer plan exclusions. Texas's large employer community means many employees are in self-insured ERISA plans that are exempt from Texas state insurance mandates. These plans can legally exclude obesity treatment entirely unless they choose to cover it.

Texas Obesity Treatment Insurance Protections

Texas Medicaid covers bariatric surgery for qualifying Medicaid enrollees meeting clinical criteria, and coverage for GLP-1 medications has been expanding for diabetic patients.

Texas Insurance Code §1369.003 requires coverage for FDA-approved drugs when used per clinical guidelines — an argument that can be made for GLP-1 drugs when prescribed for obesity-related cardiovascular disease or Type 2 diabetes.

The ACA's non-discrimination provision (Section 1557) prohibits discrimination in health coverage on the basis of disability — and severe obesity qualifies as a disability under the Americans with Disabilities Act (ADA).

Texas's IROs) Explained" class="auto-link">Independent Review Organization (IRO) process allows patients to obtain a binding independent review of medical necessity denials from an insurer.

The ACA's essential health benefits rule requires certain non-grandfathered individual and small group plans to cover preventive services and chronic disease management — arguments applicable to obesity care.

Step-by-Step: How to Appeal an Obesity Treatment Denial in Texas

Step 1 — Get the denial in writing. Request the full denial letter with the denial reason, specific criteria used, and your appeal rights and deadlines.

Step 2 — Build a medical necessity case. Your physician should write a detailed letter documenting your BMI, obesity-related comorbidities (Type 2 diabetes, hypertension, OSA, heart disease, GERD, joint disease), your history of prior weight loss attempts, and the clinical necessity of the proposed treatment. Reference AACE, Endocrine Society, or American Society for Metabolic and Bariatric Surgery (ASMBS) guidelines.

Step 3 — Challenge the drug exclusion or step therapy requirement. For GLP-1 drugs, request a formulary exception citing medical necessity and lack of clinically equivalent alternatives. For step therapy, document all prior treatments and outcomes.

Step 4 — File an internal appeal. Submit within the deadline on your denial letter (typically 180 days for ACA-regulated plans).

Step 5 — Request a peer-to-peer review. Ask your doctor or bariatric surgeon to speak with the insurer's medical director. Many denials are reversed at this stage.

Step 6 — File an IRO request through TDI.

• Texas Department of Insurance: 1-800-252-3439
• Online: www.tdi.texas.gov/consumer/complain.html

Step 7 — Escalate to ERISA federal appeal if your plan is self-insured. Contact the U.S. Department of Labor at 1-866-444-3272.

Texas Insurance Regulator Contact

Texas Department of Insurance (TDI) P.O. Box 12030, Austin, TX 78711-2030 Consumer Help Line: 1-800-252-3439 Online: www.tdi.texas.gov/consumer/complain.html

Fight Back With ClaimBack

Texas insurance denials for obesity treatment are legally contestable — especially for GLP-1 medications when prescribed for cardiovascular risk reduction or diabetes. ClaimBack helps you craft a targeted, clinically grounded appeal.

Start your appeal now at ClaimBack

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs. External Insurance Appeal: What's the Difference?